Educational Intervention on Oral Anticancer Agents for Community Pharmacists: Pilot RCT

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMonash University Malaysia

About this trial

The overall aim of this study is to develop and test the feasibility and acceptability of an educational intervention for community pharmacists to help them support patients receiving OAAs in the community setting. This pilot randomized controlled trial aims to evaluate the feasibility, acceptability, and preliminary effect of an educational intervention on the knowledge and readiness in managing OAAs among community pharmacists in Malaysia.

PRIMARY OBJECTIVE • To evaluate the feasibility and acceptability of the educational intervention on OAAs among community pharmacists.

SECONDARY OBJECTIVE

• To obtain preliminary data on the effectiveness of the educational intervention to improve community pharmacists' knowledge and confidence in managing OAAs.

Participants will be randomly assigned to either the intervention group or control group in a 1:1 ratio using block randomization. After enrolling, participants will be asked to complete a baseline survey assessing their knowledge and confidence about managing OAAs. Immediately after completing the intervention, participants in the intervention group will repeat the same questionnaire to assess changes in their knowledge and confidence.

Results of this pilot study will inform the design of a larger study to definitively test whether this intervention improves community pharmacists' knowledge and readiness. This research may help better prepare community pharmacists to provide high-quality care to patients receiving OAAs.

Eligibility criteria

Qualifiers

Currently a registered pharmacist working in community pharmacy in Malaysia

Provided written informed consent

Ability to read and understand English

Basic digital literacy and ability to use computer/tablet devices

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Educational intervention on managing oral anticancer agents in community pharmacy setting

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators